After grouping depression patients according to length of hospital stay, except for CD4+ Tn MM, CD4+ Tcm MM in the routine-term hospitalization group, there was no significant improvement in MM of other CD4+ T subpopulations before and after treatment. This evidence concerns the gene CD4 and depressive symptom measurement.